Clinical Trial Update: RCT Study of Levosimendan Improving Prognosis of Cardiac Arrest [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating levosimendan for improving prognosis after cardiac arrest is ongoing with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Arrest

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Heart Arrest | Phase 4 | Status: UNKNOWN